Study of Combined Ionizing Radiation and Ipilimumab in Metastatic Non-small Cell Lung Cancer (NSCLC)
Clinical trial NCT02221739 · COMPLETED
Trial details
- NCT number
- NCT02221739
- Sponsor
- NYU Langone Health
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-01
- Primary completion
- 2015-04-15
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.